Greenway, Frank L.

Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation

Ravussin, E., Sanchez-Delgado, G., Martin, C. K., Beyl, R. A., Greenway, F. L., O’Farrell, L. S., Roell, W. C., Qian, H.-R., Li, J., Nishiyama, H., et al. (2025) · Cell Metabolism

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 72

The impact of physical activity on the prevention of type 2 diabetes: Evidence and lessons learned from the Diabetes Prevention Program, a long-standing clinical trial incorporating subjective and objective activity measures

Kriska, A. M., Rockette-Wagner, B., Edelstein, S. L., Bray, G. A., Delahanty, L. M., Hoskin, M. A., Horton, E. S., Venditti, E. M., Knowler, W. C., DPP Research Group, et al. (2021) · Diabetes Care

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Obesity medications in development

Rebello, C. J., & Greenway, F. L. (2020) · Expert Opinion on Investigational Drugs

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 62

Combination therapy with naltrexone and bupropion for obesity reduces total and visceral adiposity

Smith, S. R., Fujioka, K., Gupta, A. K., Billes, S. K., Burns, C., Kim, D., Dunayevich, E., & Greenway, F. L. (2013) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 55

Physical function following a long-term lifestyle intervention among middle aged and older adults with type 2 diabetes: the Look AHEAD study

Houston, D. K., Neiberg, R. H., Miller, M. E., Hill, J. O., Jakicic, J. M., Johnson, K. C., Gregg, E. W., Hubbard, V. S., Pi-Sunyer, X., Rejeski, W. J., et al. (2018) · The Journals of Gerontology: Series A

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 52

Orlistat 60 mg Reduces Visceral Adipose Tissue: A 24‐Week Randomized, Placebo‐Controlled, Multicenter Trial

Smith, S. R., Stenlof, K. S., Greenway, F. L., McHutchison, J., Schwartz, S. M., Dev, V. B., Berk, E. S., & Kapikian, R. (2011) · Obesity

Pharmacology and Obesity TreatmentBariatric Surgery and Outcomes

Cited by 51

Glucagon‐like peptide ‐1 receptor agonist ‐based agents and weight loss composition: Filling the gaps

Dubin, R. L., Heymsfield, S. B., Ravussin, E., & Greenway, F. L. (2024) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 47

Single-Dose Pharmacokinetics of Different Oral Sodium Nitrite Formulations in Diabetes Patients

Greenway, F. L., Predmore, B. L., Flanagan, D. R., Giordano, T., Qiu, Y., Brandon, A., Lefer, D. J., Patel, R. P., & Kevil, C. G. (2012) · Diabetes Technology & Therapeutics

Diabetic Foot Ulcer Assessment and ManagementNitric Oxide and Endothelin Effects

Cited by 43

Energy metabolic adaptation and cardiometabolic improvements one year after gastric bypass, sleeve gastrectomy, and gastric band

Tam, C. S., Redman, L. M., Greenway, F., LeBlanc, K. A., Haussmann, M. G., & Ravussin, E. (2016) · The Journal of Clinical Endocrinology & Metabolism

Bariatric Surgery and OutcomesMinimally Invasive Surgical Techniques

Cited by 42

Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial

Wexler, D. J., de Boer, I. H., Ghosh, A., Younes, N., Bebu, I., Inzucchi, S. E., McGill, J. B., Mudaliar, S., Schade, D., Steffes, M. W., et al. (2023) · JAMA Internal Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 39

Acute Effects of a Spinach Extract Rich in Thylakoids on Satiety: A Randomized Controlled Crossover Trial

Rebello, C. J., Chu, J., Beyl, R., Edwall, D., Erlanson-Albertsson, C., & Greenway, F. L. (2015) · Journal of the American College of Nutrition

Regulation of Appetite and ObesityPharmacology and Obesity Treatment

Cited by 37

The Diabetes Prevention Program and Its Outcomes Study: NIDDK’s Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact

Crandall, J. P., Dabelea, D., Knowler, W. C., Nathan, D. M., Temprosa, M., DPP Research Group, Bray, G. A., Gadde, K. M., Culbert, I. W., Arceneaux, J., et al. (2025) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 29

Effect of exercise training on insulin-stimulated glucose disposal: A systematic review and meta-analysis of randomized controlled trials

Rebello, C. J., Zhang, D., Kirwan, J. P., Lowe, A. C., Emerson, C. J., Kracht, C. L., Steib, L. C., Greenway, F. L., Johnson, W. D., & Brown, J. C. (2023) · International Journal of Obesity

Diabetes, Cardiovascular Risks, and LipoproteinsPhysical Activity and Health

Cited by 16

Weight Change During the Postintervention Follow-up of Look AHEAD

Wing, R. R., Neiberg, R. H., Bahnson, J. L., Clark, J. M., Espeland, M. A., Hill, J. O., Johnson, K. C., Knowler, W. C., Olson, K., Steinburg, H., et al. (2022) · Diabetes Care

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Treatment and Management

Cited by 14

A Statistical Analysis of a Traffic-Light Food Rating System to Promote Healthy Nutrition and Body Weight

Larrivee, S., Greenway, F. L., & Johnson, W. D. (2015) · Journal of Diabetes Science and Technology

Consumer Attitudes and Food LabelingNutrition, Health and Food Behavior

Cited by 9

Leucine and sildenafil combination therapy reduces body weight and metformin enhances the effect at low dose: a randomized controlled trial

Rebello, C. J., Zemel, M. B., Kolterman, O., Fleming, G. A., & Greenway, F. L. (2021) · American Journal of Therapeutics

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 8

Weight Loss With Self-help Compared With a Structured Commercial Program: A Randomized Trial

Heshka, S., Anderson, J. W., Atkinson, R. L., Greenway, F. L., Hill, J. O., Phinney, S. D., Kolotkin, R. L., Miller-Kovach, K., & Pi-Sunyer, F. X. (2003) · JAMA

Obesity, Physical Activity, DietPharmacology and Obesity Treatment

Cited by 7

Weight Loss Maintenance With Once-Weekly Semaglutide 2.4 MG in Adults With Overweight or Obesity Reaching Maintenance Dose (STEP 4)

Rubino, D. M., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., Lingvay, I., Mosenzon, O., Rosenstock, J., Rubio, M. A., et al. (2021) · Journal of the Endocrine Society

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 3